ONCAlert | 2017 NANETS Symposium

An Overview of a Study Combining MOR208 With Lenalidomide in CLL

Jennifer Woyach, MD
Published Online:1:03 PM, Tue December 20, 2016

Jennifer Woyach, MD, associate professor, Ohio State University, discusses a study combining MOR208 with Lenalidomide for the treatment of chronic lymphocytic leukemia (CLL). 
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.